Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities

por Pezo, Rossanna C., Wong, Matthew, Martin, Alberto
Publicado 2019

Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with Immunotherapy

por Angrish, Manish D., Agha, Arun, Pezo, Rossanna C.
Publicado 2021

Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte–associated protein 4 therapy: A r...

por Naderi-Azad, Sheida, Sickandar, Faisal, Pezo, Rossanna C.
Publicado 2020

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review

por Komorowski, Adam S., MacKay, Helen J., Pezo, Rossanna C.
Publicado 2020

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

por Blanchette, Phillip, Sivajohanathan, Duvaraga, Bartlett, John, Eisen, Andrea, Feilotter, Harriet, Pezo, Rossanna, Turashvili, Gulisa, Williams, Phillip
Publicado 2022

Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer

por Pezo, Rossanna C., Chen, Tom W., Berman, Hal K., Mulligan, Anna M., Razak, Albiruni A., Siu, Lillian L., Cescon, David W., Amir, Eitan, Elser, Christine, Warr, David G., Sridhar, Srikala S., Yu, Celeste, Wang, Lisa, Stockley, Tracy L., Kamel-Reid, Suzanne, Bedard, Philippe L.
Publicado 2017

Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer

por Bailey, Swneke D., Desai, Kinjal, Kron, Ken J., Mazrooei, Parisa, Sinnott-Armstrong, Nicholas A., Treloar, Aislinn E., Dowar, Mark, Thu, Kelsie L., Cescon, David W., Silvester, Jennifer, Yang, S. Y. Cindy, Wu, Xue, Pezo, Rossanna C., Haibe-Kains, Benjamin, Mak, Tak W., Bedard, Philippe L., Pugh, Trevor J., Sallari, Richard C., Lupien, Mathieu
Publicado 2016

Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors

por Tonneau, Marion, Nolin-Lapalme, Alexis, Kazandjian, Suzanne, Auclin, Edouard, Panasci, Justin, Benlaifaoui, Myriam, Ponce, Mayra, Al-Saleh, Afnan, Belkaid, Wiam, Naimi, Sabrine, Mihalcioiu, Catalin, Watson, Ian, Bouin, Mickael, Miller, Wilson, Hudson, Marie, Wong, Matthew K., Pezo, Rossanna C., Turcotte, Simon, Bélanger, Karl, Jamal, Rahima, Oster, Paul, Velin, Dominique, Richard, Corentin, Messaoudene, Meriem, Elkrief, Arielle, Routy, Bertrand
Publicado 2022